Timber Pharmaceuticals, Inc.
(NYSE Amex Equities : TMBR)

( )
TMBR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.22%159.760.7%$1206.02m
PFEPfizer Inc. 0.24%37.280.9%$1007.47m
MRKMerck & Co., Inc. 0.17%76.560.7%$968.36m
ABBVAbbVie, Inc. 0.28%106.301.9%$822.66m
BMYBristol-Myers Squibb Co. -0.06%63.801.0%$725.39m
LLYEli Lilly & Co. 0.07%183.131.1%$599.57m
AZNAstraZeneca Plc 0.92%50.301.2%$444.76m
GSKGlaxoSmithKline Plc -1.87%35.450.2%$175.70m
RPRXRoyalty Pharma Plc 0.00%42.120.2%$163.20m
NVSNovartis AG 0.21%86.930.2%$149.38m
VTRSViatris, Inc. 0.00%13.210.0%$129.35m
CVACCureVac NV 7.11%109.900.0%$88.92m
RGENRepligen Corp. 0.00%205.296.8%$87.69m
ATNF180 Life Sciences Corp. 1.43%10.610.0%$63.57m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.16%74.920.0%$61.28m

Company Profile

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. The company is headquartered in Woodcliff Lake, NJ.